SMARCA4-Deficient Undifferentiated Thoracic Tumor: Clinical Features and Prognosis of a Case Series and Literature

Fangzhen Shan1, Shuntao Liang2, Youwen Zhang3

  • 1Medical Research Center, Affiliated Hospital of Jining Medical University, Shandong, China.

PubMed
Abstract

Insights

Thoracic SMARCA4-deficient undifferentiated tumors (SMARCA4-UT) are aggressive neoplasms. Immunotherapy and targeted agents show promise for managing SMARCA4-UT, suggesting new therapeutic avenues.

Area of Science:

  • Oncology
  • Genetics
  • Pathology

Background:

  • Thoracic SMARCA4-deficient undifferentiated tumors (SMARCA4-UT) are rare, aggressive epithelioid neoplasms.
  • These tumors are characterized by SMARCA4 gene loss and typically diagnosed at advanced stages with poor prognosis.
  • Current treatment lacks standardized protocols and approved targeted therapies.

Purpose of the Study:

  • To present a case series of nine patients with thoracic SMARCA4-UT.
  • To detail demographic, pathological, imaging, and treatment data for these patients.
  • To conduct a literature review and genomic analysis of SMARCA4 mutations in lung cancer.

Main Methods:

  • Case series of nine patients with thoracic SMARCA4-UT.
  • Comprehensive literature review.
  • Genomic analysis of SMARCA4 mutations in lung cancer.

Main Results:

  • The cohort consisted of predominantly male smokers (mean age 63 years).
  • All cases showed loss of BRG1 expression, negative for TTF-1 and p40, with preserved SMARCB1/INI-1.
  • Patients responded poorly to chemotherapy but showed partial response to immunotherapy or targeted agents. SMARCA4 mutations are linked to poorer lung cancer prognosis.

Conclusions:

  • Immunotherapy and targeted therapies demonstrate potential for managing thoracic SMARCA4-UT.
  • Further investigation into these treatment modalities is warranted.
  • Exploring the tumor's genetic and molecular landscape may reveal novel therapeutic targets.

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
500
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
463
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
309
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
435
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
294